Break it Down: Optiscan progresses real-time telepathology platform to minimum viable product stage

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully looks at the latest from Optiscan (ASX:OIL), who have progressed its cloud-based telepathology streaming software project to minimum viable product stage.  

Watch the video to find out the latest.

While Opitscan is a Stockhead advertiser, it did not sponsor this content.